Suppr超能文献

对乙酰氨基酚及低剂量间歇性地西泮预防热性惊厥复发的作用。

Effect of acetaminophen and of low intermittent doses of diazepam on prevention of recurrences of febrile seizures.

作者信息

Uhari M, Rantala H, Vainionpää L, Kurttila R

机构信息

Department of Pediatrics, University of Oulu, Finland.

出版信息

J Pediatr. 1995 Jun;126(6):991-5. doi: 10.1016/s0022-3476(95)70231-8.

Abstract

Acetaminophen and low doses of diazepam were evaluated for the prevention of recurrences of febrile seizures in a placebo-controlled, double-blind trial. Children after their first febrile seizure were assigned to receive either one dose of rectally administered diazepam, and then, after 6 hours, oral doses of 0.2 mg/kg three times a day for the first 2 days if the fever stayed greater than 38.5 degrees C, or a placebo similarly during forthcoming febrile episodes. In addition, each febrile episode was randomly assigned to be treated with acetaminophen or the placebo. Thus four groups were examined for 2 years: patients receiving two kinds of placebo, patients receiving diazepam and a placebo, patients receiving acetaminophen and a placebo, and patients receiving both diazepam and acetaminophen. Of a total of 180 patients (102 boys), 161 were followed for the 2-year period and 157 were seen at the last outpatient examination: 80 in the diazepam group and 77 in the placebo group. The final analysis of the efficacy of the drugs was made on the basis of the data from 153 patients who had had at least one febrile episode during follow-up. There were 641 fever events during this period, and 38 children (21.1%) had 55 recurrences of febrile seizures. Acetaminophen had no effect on the recurrence rate. Seizures recurred at least once in 21 patients (28.4%) receiving diazepam and 17 (21.5%) receiving a placebo (p = 0.4138, log-rank test). The combination of antipyretic agents with anticonvulsant medication did not reduce the recurrence of febrile seizures. Our results show that low doses of acetaminophen or diazepam or both are ineffective for preventing febrile seizures.

摘要

在一项安慰剂对照、双盲试验中,对乙酰氨基酚和低剂量地西泮预防热性惊厥复发的效果进行了评估。首次发生热性惊厥后的儿童被分配接受一剂经直肠给予的地西泮,然后,如果发热持续高于38.5摄氏度,在接下来的2天内,每天分3次口服0.2mg/kg的剂量;或者在即将到来的发热发作期间同样接受安慰剂治疗。此外,每次发热发作被随机分配接受乙酰氨基酚或安慰剂治疗。因此,四组患者接受了为期2年的观察:接受两种安慰剂的患者、接受地西泮和安慰剂的患者、接受乙酰氨基酚和安慰剂的患者,以及接受地西泮和乙酰氨基酚两者的患者。在总共180例患者(102名男孩)中,161例接受了为期2年的随访,157例在最后一次门诊检查时前来就诊:地西泮组80例,安慰剂组77例。根据153例在随访期间至少发生过一次发热发作的患者的数据,对药物疗效进行了最终分析。在此期间共有641次发热事件,38名儿童(21.1%)出现了55次热性惊厥复发。乙酰氨基酚对复发率没有影响。接受地西泮的21例患者(28.4%)和接受安慰剂的17例患者(21.5%)至少有一次惊厥复发(p = 0.4138,对数秩检验)。退热剂与抗惊厥药物联合使用并不能降低热性惊厥的复发率。我们的结果表明,低剂量的乙酰氨基酚或地西泮或两者对预防热性惊厥均无效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验